Add Company
Join Now

DEM Biopharma Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • DEM Biopharma's estimated annual revenue is currently $4.3M per year.(i)
  • DEM Biopharma's estimated revenue per employee is $77,500

Employee Data

  • DEM Biopharma has 55 Employees.(i)
  • DEM Biopharma grew their employee count by 67% last year.

DEM Biopharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial Officer/Chief Operating OfficerReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Director, Drug DiscoveryReveal Email/Phone
5
Sr. Director, Antibody Discovery & DevelopmentReveal Email/Phone
6
Associate Director, Pharmacology/ToxicologyReveal Email/Phone
7
Associate DirectorReveal Email/Phone
8
Associate Director, Lab Operations and FacilitiesReveal Email/Phone
9
Executive Assistant/Office ManagerReveal Email/Phone
10
Scientist 1Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is DEM Biopharma?

DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$4.3M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M55-62%$281.5M
#2
$7.6M55-7%$128.2M
#3
$8.4M556%N/A
#4
$8.5M5541%N/A
#5
$6.9M5515%N/A